Clinical, serological and genetic study in patients with CREST syndrome

被引:34
作者
Akiyama, Y [1 ]
Tanaka, M [1 ]
Takeishi, M [1 ]
Adachi, D [1 ]
Mimori, A [1 ]
Suzuki, T [1 ]
机构
[1] Saitama Med Sch, Dept Rheumatol, Moroyama, Saitama 3500495, Japan
关键词
antimitochondrial antibody; human histocompatibility leukocyte antigens; primary biliary cirrhosis; Sjogren's syndrome; tricuspid regurgitation;
D O I
10.2169/internalmedicine.39.451
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the clinical, serological and genetic features of Japanese patients with CREST syndrome. Patients and Methods Clinical features, autoantibodies and human histocompatibility leukocyte antigen (HLA) typing were studied in thirty patients with CREST syndrome, including 29 females and one male, with a mean age of 59.0 years (ranging from 40 to 76 years). Results Interstitial pneumonia on chest X-ray and renal involvement were rare. Mitral regurgitation and tricuspid regurgitation were present in 56.7% and 76.7%, respectively. Sjoren's syndrome (SS) and primary biliary cirrhosis (PBC) were highly associated, however the positivity of the marker antibodies to those syndromes, such as anti-SSA, anti-SSB, anti-mitochondrial (AMA) and antismooth muscle autoantibodies were less frequent than that of primary SS and PBC without the other autoimmune diseases, The histological findings of PBC were all early stages in Scheuer's classification. HLA-Cw6 were associated with CREST-PBC overlap syndrome (p<0.05). However the HLA antigen was not correlated with CREST syndrome, and the frequency of HLA-DR2 between CREST syndrome with or without PBC was significantly different (p<0.01). Conclusion It was suggested that there was a genetic difference between CREST syndrome alone and CREST-PBC overlap syndrome and there were differences (the positivity of AMA and the severity of bile duct lesion) between PBC and CREST-PBC overlap syndrome.
引用
收藏
页码:451 / 456
页数:6
相关论文
共 21 条
  • [1] Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis
    CandellRiera, J
    ArmadansGil, L
    Simeon, CP
    CastellConesa, J
    FonollosaPla, V
    GarciaDelCastillo, H
    VaqueRafart, J
    Vilardell, M
    SolerSoler, J
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (07): : 1138 - 1145
  • [2] DROSOS AA, 1991, J RHEUMATOL, V18, P1685
  • [3] HOMMA M, 1986, SCAND J RHEUMATOL, P26
  • [4] JUJI T, 1983, ANN REPORT MINISTRY, P128
  • [5] ASSOCIATION OF PROGRESSIVE SYSTEMIC SCLERODERMA TO SEVERAL HLA-B AND HLA-DR ALLELES
    LUDERSCHMIDT, C
    SCHOLZ, S
    MEHLHAFF, E
    KONIG, G
    ALBERT, E
    [J]. ARCHIVES OF DERMATOLOGY, 1987, 123 (09) : 1188 - 1191
  • [6] ANTICENTROMERE ANTIBODY - CLINICAL CORRELATIONS AND ASSOCIATION WITH FAVORABLE PROGNOSIS IN PATIENTS WITH SCLERODERMA VARIANTS
    MCCARTY, GA
    RICE, JR
    BEMBE, ML
    BARADA, FA
    [J]. ARTHRITIS AND RHEUMATISM, 1983, 26 (01): : 1 - 7
  • [7] EPIDEMIOLOGY OF SYSTEMIC SCLEROSIS (SCLERODERMA)
    MEDSGER, TA
    MASI, AT
    [J]. ANNALS OF INTERNAL MEDICINE, 1971, 74 (05) : 714 - +
  • [8] AUTOANTIBODY TO CENTROMERE (KINETOCHORE) IN SCLERODERMA SERA
    MOROI, Y
    PEEBLES, C
    FRITZLER, MJ
    STEIGERWALD, J
    TAN, EM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (03): : 1627 - 1631
  • [9] NISHIMAKI T, 1991, J CLIN EXPT MED, V159, P139
  • [10] OMOTO R, 1984, JPN HEART J, V25, P325